Karyopharm Therapeutics Inc
(NAS:KPTI)
$
0.993
0.0273 (2.88%)
Market Cap: 123.74 Mil
Enterprise Value: 151.60 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 71/100 Karyopharm Therapeutics Inc (KPTI) Transcripts
- Q1 2024 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 08, 2024$1.02 (-7.27%)Earnings
- Q4 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 29, 2024$1.16 (-12.78%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2023$0.7613 (-3.17%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Karyopharm Therapeutics Inc at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Q2 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 02, 2023$1.79 (-0.56%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 04, 2023$2.77 (-24.32%)Earnings
- Karyopharm Therapeutics Inc to Host Investor Webcast on Selinexor Data in Patients with Treatment-Naive Myelofibrosis at AACR 2023 TranscriptApr 18, 2023
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 15, 2023$3.66 (+10.24%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Karyopharm Therapeutics Inc Investor and Analyst Event at ASH TranscriptDec 12, 2022
- Q3 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2022$4.54 (-4.62%)Earnings
- Karyopharm Therapeutics Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2022
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2022$4.53 (+0.67%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Karyopharm Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2022$6.74 (+1.20%)Earnings
- Karyopharm Therapeutics Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- Karyopharm Therapeutics Inc SIENDO Study Results Call TranscriptMar 17, 2022
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Karyopharm Therapeutics Inc Earnings, 2022 Financial Outlook and SIENDO Topline Results Discussion Call TranscriptFeb 08, 2022
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Karyopharm Therapeutics Inc Virtual Investor Day TranscriptDec 08, 2021
- Karyopharm Therapeutics Inc at Jefferies London Healthcare Conference (Virtual) - On-Demand TranscriptNov 18, 2021
- Q3 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2021$7.94 (+37.37%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Karyopharm Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) - Pre-Recorded TranscriptSep 13, 2021
- Q2 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 05, 2021$5.93 (-24.17%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2021
- Q1 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 03, 2021$9.44 (+1.07%)Earnings
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 11, 2021$15.35 (-3.28%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Karyopharm Therapeutics Inc - Karyopharm XPOVIO® FDA Approval in Multiple Myeloma Conference Call TranscriptDec 18, 2020
- Karyopharm Therapeutics Inc - Investor And Analyst ASH Event (Virtual) TranscriptDec 08, 2020
- Karyopharm Therapeutics Inc - Phase 3 SEAL Top-Line Results Conference Call TranscriptNov 20, 2020
- Karyopharm Therapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2020$14.5 (-2.16%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2020$15.76 (-6.52%)Earnings
- Karyopharm Therapeutics Inc to Discuss The FDA's Approval Of XPOVIO TranscriptJun 22, 2020
- Karyopharm Therapeutics Inc BOSTON Data Conference Call TranscriptMay 29, 2020
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Karyopharm Therapeutics Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2020$19.63 (-5.08%)Earnings
- Karyopharm Therapeutics Inc - Discuss Selinexor As A Potential Treatment For Hospitalized Patients With COVID-19 TranscriptApr 07, 2020
- Karyopharm Therapeutics Inc. Phase 3 BOSTON Study Top-line Results Conference Call TranscriptMar 02, 2020
- Q4 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 13, 2020$16.07 (-4.52%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 04, 2019$13.32 (+6.22%)Earnings
- Q2 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 06, 2019$8.3 (+5.73%)Earnings
- Karyopharm Therapeutics Inc Corporate Call TranscriptJul 03, 2019
- Karyopharm Therapeutics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Q1 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 09, 2019$4.63 (-1.70%)Earnings
- Q4 2018 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 28, 2019$4.13 (-6.14%)Earnings
- 1